183.50
-4.50
(-2.39%)
As of 10:57:34 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 12 |
| Avg. Estimate | 9.09B | 9.39B | 39.47B | 43.71B |
| Low Estimate | 8.92B | 9.18B | 38.64B | 41B |
| High Estimate | 9.42B | 9.61B | 40.03B | 47.09B |
| Year Ago Sales | 16.05B | 9.09B | 38.7B | 39.47B |
| Sales Growth (year/est) | -43.35% | 3.31% | 2.00% | 10.74% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GCP.F | -- | -- | -- | -- |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Maintains | RBC Capital: Outperform to Outperform | 1/24/2025 |
| Maintains | UBS: Buy to Buy | 1/24/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 1/24/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 1/24/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 1/22/2025 |
| Maintains | Deutsche Bank: Buy to Buy | 1/2/2025 |